key: cord-0939495-vml7h7mf
authors: Cioffi, Andrea; Cioffi, Fernanda
title: COVID-19 Vaccine: Risk of Inequality and Failure of Public Health Strategies
date: 2021-03-19
journal: Ethics Med Public Health
DOI: 10.1016/j.jemep.2021.100653
sha: a569aa99b1770d263fcc24d2826b03e51dfef0b1
doc_id: 939495
cord_uid: vml7h7mf

nan

to this joint fund, by the end of 2021, it is hoped that 2 billion doses will be distributed to lowmiddle-income countries. However, at the moment, the vaccination campaign is carried out mainly in high-income countries and, therefore, in developing countries there is still a considerable exposure and spread to COVID-19 [8] . In addition, it is important to stress that both the distribution of vaccines in low-middle-income countries and vaccination campaigns will take a long time. So, actually, rich countries will get access to COVID-19 vaccines earlier than poor ones. In some lowincome countries widespread vaccination coverage will be achieved after 2023 [9] . This means that the richest citizens of the world can be vaccinated and can prevent the consequences, even deadly, of COVID-19, while the poorest citizens will be much more exposed to the infection with potentially serious risks to their health. Obviously, this situation generates a serious inequality, once again, based on the wealth of a nation or a single citizen [10] .

Today's reality is, therefore, marked by a considerable contradiction with respect to the provisions for the protection of human rights over time.

In fact, as early as 1948, Article 25 of the Universal Declaration of Human Rights stated that "Everyone has the right to a standard of living adequate for the health and well-being of himself and of his family, including food, clothing, housing and medical care and necessary social services". In These statutes, pacts etc. are certainly reassuring to read but, unfortunately -as demonstrated by the current evolution of the anti-COVID-19 vaccination campaign -seem to be just theories, fair, admirable but with a reduced real and practical feedback.

The inequality of the distribution of vaccines against SARS-CoV-2 has not only bioethical consequences but also public health consequences.

In fact, the possibility that billions of people will not be vaccinated before 2023 will cause a continued uncontrolled spread of COVID-19 around the world. One of the main risks of this constant spread is the development of further variants of SARS-Cov-2 that could, in the future, also make totally ineffective vaccines today on the market with significant consequences on global health and the world economy. In fact, the greater the number of subjects infected by SARS-CoV-2, the greater the risk of producing new viral variants. The most effective solution to reduce this risk is to drastically reduce the spread of the virus and the number of infected subjects.

As a result, a global effort will be needed which must involve above all high-income countries. In fact, it is considered that COVAX Joint is not, alone, sufficient to meet the need for vaccines in lowmiddle-income countries. Therefore, the participation, including economic participation, of the richest and most developed states will be of crucial importance. Only in this way will it be possible to vaccinate the maximum number of citizens with positive bioethical implications but also with optimal global health results.

It is precisely in these moments of critical emergency that National Health Systems, world governments, pharmaceutical companies, can demonstrate that the health equity and health equality are not only a just and reassuring theory, but are inviolable rights of every human being.

COVID-19 and abortion: The importance of guaranteeing a fundamental right

COVID-19 and healthcare-associated infections

Covid-19 and medical liability: A delicate balance

CoViD-19 and psychiatry: can mental illness justify further exceptions to the obligation to stay at home?

Intensive and pharmacological care in times of COVID-19: A "special ethics" for emergency

Coronavirus disease 2019: is everything lawful to create an effective vaccine?

How COVID vaccines are being divvied up around the world

Data. Coronavirus (COVID-19) Vaccinations. Available to

More than 85 poor countries will not have widespread access to coronavirus vaccines before 2023

Public and private health services: wait times for health services and the risk of inequality from the Italian perspective